ICON Plc - Company Profile

Powered by

All the data and insights you need on ICON Plc in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date ICON Plc Strategy Report

  • Understand ICON Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

ICON Plc: Overview

Select Item

ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides specialized services that span the entire lifecycle of product development. The company’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, provision of functional services, medical imaging, resourcing solutions, laboratory services and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, non-alcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, and women’s health, among others. ICON is headquartered in Dublin, Ireland.

 Gain a 360-degree view of ICON Plc and make more informed decisions for your business Gain a 360-degree view of ICON Plc and make more informed decisions for your business Find out more
Headquarters Ireland
Address South County Business Park, Leopardstown, Dublin, 18
Website www.iconplc.com
Telephone 353 1 2912000
No of Employees 41,100
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ICLR (NASD)
Revenue (2022) $8.1B 4.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 21.2% (2022 vs 2021)
Market Cap* $25.2B
Net Profit Margin (2022) XYZ 15.5% (2022 vs 2021)
* As of and is in US$
View ICON Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

ICON Plc premium industry data and analytics

1,500+

Clinical Trials

Determine ICON Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,000+

Catalyst Calendar

Proactively evaluate ICON Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

430+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for ICON Plc’s relevant decision makers and contact details.

220+

Investigators

Review investigator profiles and find information on trial contacts across ICON Plc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

100+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

5

Marketed Drugs

Understand ICON Plc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on ICON Plc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Services
Adaptive Trials
Laboratory Services
Functional Services Provision
XYZ
XYZ
XYZ
Understand ICON Plc portfolio and identify potential areas for collaboration Understand ICON Plc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Acquisitions/Mergers/Takeovers In February, the company acquired HumanFirst.
2023 New Products/Services In September, the company launched next generation Clinical Trial Tokenisation solution.
2023 Contracts/Agreements In September, the company entered into a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to execute a clinical trial to evaluate the effectiveness of next generation COVID-19 vaccine candidates.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters ICON Plc IQVIA Holdings Inc Laboratory Corp of America Holdings Syneos Health Inc Almac Group Ltd
Headquarters Ireland United States of America United States of America United States of America United Kingdom
City Dublin Durham Burlington Morrisville Craigavon
State/Province Dublin North Carolina North Carolina North Carolina Northern Ireland
No. of Employees 41,100 87,000 67,000 28,768 6,600
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Steve Cutler Ph.D Director; Chief Executive Officer Executive Board 2017 62
Tom O'Leary Chief Information Officer Senior Management - -
Diarmaid Cunningham Secretary; General Counsel; Chief Administrative Officer Senior Management 2016 48
Joe Cronin Chief Human Resources Officer Senior Management - -
Greg Licholai Chief Medical & Innovation Officer Senior Management 2021 58
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into ICON Plc key executives to enhance your sales strategy Gain insight into ICON Plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward